The Importance of CDI (CAS 530-62-1) in Peptide Synthesis

Why CDI matters for peptide chemists

1,1′-Carbonyldiimidazole (CDI, CAS 530-62-1) is one of the most reliable activating reagents in peptide chemistry. By converting a carboxylic acid into a highly reactive acyl imidazole intermediate, CDI cleanly enables amide bond formation with amines under mild conditions — producing only imidazole and CO₂ as by-products.

This clean reaction profile makes CDI an ideal alternative to harsher reagents such as thionyl chloride, oxalyl chloride, or phosgene, and a complementary tool alongside HATU, HBTU, EDC, and DCC.

Key benefits in peptide synthesis

CDI activation is widely used in both solution-phase peptide synthesis and large-scale fragment coupling for therapeutic peptides such as GLP-1 analogs, oxytocin derivatives, and antimicrobial peptides.

• Mild, near-neutral activation — minimal epimerization at α-stereocenters
• Clean by-products (imidazole + CO₂) simplify downstream purification
• Compatible with Fmoc and Boc protecting group strategies
• Safe phosgene substitute for carbamate and urea linker chemistry
• Excellent solubility in THF, DMF, DCM, and acetonitrile

CDI for GMP and commercial peptide manufacturing

Because CDI generates non-toxic by-products and operates at moderate temperatures, it is heavily favored in cGMP peptide API manufacturing where impurity control is critical. Process chemists rely on CDI for late-stage fragment couplings, macrolactamizations, and the installation of urea or carbamate motifs in peptidomimetics.

MT Chemtech supplies pharmaceutical-grade CDI (≥99% HPLC) in bulk drum quantities to peptide CDMOs and API manufacturers worldwide.